5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sanofi Consumer Healthcare India Ltd.

•
sanofi.inBSE: 544250NSE: SANOFICONR
Market Cap₹ 9,327 Cr.
Current Price
High / Low₹ 5,357 / 3,975
Stock P/E35.1
Book Value₹ 151
Price to Book27.11
Dividend Yield1.85 %
ROCE98.1 %
ROE73.2 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 102.7%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 80.6%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.05x)
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Stock is trading at 27.1x its book value
  • Recurring exceptional / one-off items are inflating headline profit
  • Rich enterprise valuation - EV/EBITDA of 30.7x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY MICROCAP250NIFTY TOTAL MKT
S.No.Name
1.SUNPHARMA1868.5037.06448315.740.862901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9482.7586.06251737.220.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4931.9086.01187593.620.77566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1129.0024.95112618.180.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1368.0032.79110515.040.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1933.2595.54104455.860.10362.07123.942026.3129.1018.2031.50
7.AUROPHARMA1690.0026.1997238.860.241032.0325.229150.3517.4412.7620.54
8.LUPIN2092.0017.3095660.020.861416.9816.018276.8934.2828.8629.59
9.DRREDDY1143.2029.6195420.610.70435.60-69.108099.80-5.2113.7510.63
10.MANKIND2266.0045.8293596.020.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2439.5538.2968850.120.10482.83927.884018.4831.3520.3520.03
12.SANOFICONR4049.8535.069327.061.8568.8013.34235.706.7098.1137.89
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
100210225222172160171173221234251229236
6611613514010997109109151149161140150
Operating Profit35959082646362647085908986
OPM %34.60%44.98%39.85%36.91%36.91%39.46%36.38%37.08%31.78%36.34%35.78%38.74%36.32%
0113-24325123566
Interest0000030001000
Depreciation0111121233333
Profit before Tax34959084396163677984909192
Tax %25.22%25.21%24.22%25.27%25.45%26.47%29.46%25.15%23.07%25.21%26.52%25.25%25.14%
Net Profit26716863294544506163666869
11.1930.9229.4827.2212.5819.5219.2521.6926.3627.3128.8729.4429.87

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025TTM
555724878950
337454569601
Operating Profit219271309349
OPM %39.40%37.35%35.18%36.77%
2-152520
Interest0422
Depreciation241213
Profit before Tax219247320357
Tax %24.81%26.66%25.04%25.53%
Net Profit165181240266
EPS824.5078.70104.39—
Dividend Payout %6.06%69.89%71.85%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
-20%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
81%
Last Year:
73%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jun 19

₹ 7.50

Rs.75.0000 per share(750%)Final Dividend

2025

Apr 17

₹ 5.50

Rs.55.0000 per share(550%)Final Dividend

Dec 2023Dec 2024Dec 2025
Equity Capital22323
183249361
01717
Trade Payables607080
99188262
Total Liabilities344547742
52936
Capital Work in Progress010
974162
321430
Cash & Bank2327375
209135240
Total Assets344547742

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025
-0439175
Cash from Investing028
Cash from Financing2-116-134
232548

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025

Shareholding Pattern

Numbers in percentages

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
60.4060.4060.4071.2771.2771.2771.2771.27
5.224.424.523.242.932.832.752.60
23.8225.1524.9016.8917.2117.3317.5717.85
Government0.000.000.000.000.000.000.000.00
10.5610.0410.178.608.598.578.408.27

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-07-30
Copy of Newspaper Publication

2026-07-30 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Result for the quarter and half year ended 30th June 2026.

2026-07-28
Press Release

2026-07-28 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding a press release dated July 28, 2026.

2026-07-28
Outcome of Board Meeting

2026-07-28 - Sanofi Consumer Healthcare India Limited has submitted to the Exchange, the Unaudited Financial Results for the quarter and half year ended Jun 30, 2026.

2026-07-09
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-09 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-06-29
Change in Auditors

2026-06-29 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Change in Auditors of the company.

2026-06-29
Shareholders meeting

2026-06-29 - Sanofi Consumer Healthcare India Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 26, 2026. Further, the company has informed the Exchange regarding voting results.

2026-06-26
Shareholders meeting

2026-06-26 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 26, 2026

2026-06-26
Trading Window

2026-06-26 - Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-05
Copy of Newspaper Publication

2026-06-05 - Sanofi Consumer Healthcare India Limited has informed the Exchange about Copy of Newspaper Publication of 3rd Annual General Meeting of the Company

News

Recent coverage and analyst commentary for SANOFICONR

Loading news…

🤖

AI Stock Analyst

Sanofi Consumer Healthcare India Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme


5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login